XORTX Therapeutics Inc. filed a Form 6-K on March 19, 2024, indicating compliance with SEC reporting requirements. This filing does not indicate any adverse events or changes for the company.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.